Abstract:Background: The ansamycin class of antibiotics are produced by various Actinomycetes. Their carbon framework arises from the polyketide pathway via a polyketide synthase (PKS) that uses an unusual starter unit. Rifamycin (rif), produced by Amycolatopsis mediterranei, is the archetype ansamycin and it is medically important. Although its basic precursors (3-amino-5-hydroxy benzoic acid AHBA, and acetic and propionic acids) had been established, and several biosynthetic intermediates had been identified, very little was known about the origin of AHBA nor had the PKS and the various genes and enzymes that modify the initial intermediate been characterized. Results: A set of 34 genes clustered around the rifK gene encoding AHBA synthase were defined by sequencing all but 5 kilobases (kb) of a 95 kb contiguous region of DNA from A. mediterranei. The involvement of some of the genes in the biosynthesis of rifamycin B was examined. At least five genes were shown to be essential for the synthesis of AHBA, five genes were determined to encode the modular type I PKS that uses AHBA as the starter unit, and 20 or more genes appear to govern modification of the polyketide-derived framework, and rifamycin resistance and export. Putative regulatory genes were also identified. Disruption of the PKS genes at the end of rifA abolished rifamycin B production and resulted in the formation of P8/1-OG, a known shunt product of rifamycin biosynthesis, whereas disruption of the orf6 and orf9 genes, which may encode deoxysugar biosynthesis enzymes, had no apparent effect. Conclusions: Rifamycin production in A. mediterranei is governed by a single gene cluster consisting of structural, resistance and export, and regulatory genes. The genes characterized here could be modified to produce novel forms of the rifamycins that may be effective against rifamycin-resistant microorganisms.

Rifamorpholines A-E, Potential Antibiotics from Locust-Associated Actinobacteria Amycolatopsis Sp Hca4

8-Deoxy-Rifamycin Derivatives From Amycolatopsis Mediterranei S699 Delta Rift Strain

Rifamycin W Analogues from <i>Amycolatopsis mediterranei</i> S699 <i>rif</i>-<i>orf5</i> Strain

Rifamycin W Analogues from Amycolatopsis mediterranei S699 Δrif-orf5 Strain.

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

Discovery of Three 22-Membered Macrolides by Deciphering the Streamlined Genome of Mangrove-Derived <i>Streptomyces</i> sp. HM190

Novel Macrolactams from a Deep-Sea-Derived <i>Streptomyces</i> Species

Paenimacrolidin, a Novel Macrolide Antibiotic from Paenibacillus Sp. F6‐B70 Active Against Methicillin‐resistant Staphylococcus Aureus

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

Bioactive Polycyclic Tetramate Macrolactams From Lysobacter Enzymogenes And Their Absolute Configurations By Theoretical Ecd Calculations

Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699

Macrolides of the Bafilomycin Family Produced by Streptomyces Sp. CS

Azalomycin F-4a 2-Ethylpentyl Ester, A New Macrocyclic Lactone, from Mangrove Actinomycete Streptomyces Sp 211726

Structurally Diverse Macrolactams from an Antarctic Streptomyces Species.

Isolation of 11,12- seco-Rifamycin W Derivatives Reveals a Cleavage Pattern of the Rifamycin Ansa Chain

Synthesis and fungicidal activity of macrolactams and macrolactones with an oxime ether side chain.

Somalactams A–D: Anti‐inflammatory Macrolide Lactams with Unique Ring Systems from an Arctic Actinomycete Strain

Antimicrobial spiroketal macrolides and dichloro-diketopiperazine from Micromonospora sp. FIMYZ51

Anti-MRSA Actinomycins D1-D4 from the Marine Sponge-Associated Streptomyces Sp. LHW52447

Nagimycins A and B, Antibacterial Ansamycin-Related Macrolactams from Streptomyces sp. NA07423

Antibacterial and Antitumor Macrolides Fromstreptomyces Sp. Is9131